1Neonatal Unit, St James's University Hospital, Leeds, UK. ktan@mcmaster.ca
This study validated a point-of-care testing (POCT) device for newborn coagulation screening. The device showed promise for activated partial thromboplastin time (APTT) but was not sensitive enough for prothrombin time (PT) screening.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: